First Trust Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26,813
| Closed | -$846K | – | 2498 |
|
|
2022
Q4 | $846K | Sell |
26,813
-32,121
| -55% | -$1.01M | ﹤0.01% | 2014 |
|
|
2022
Q3 | $1.67M | Buy |
58,934
+22,175
| +60% | +$626K | ﹤0.01% | 1773 |
|
|
2022
Q2 | $972K | Sell |
36,759
-57,993
| -61% | -$1.53M | ﹤0.01% | 1999 |
|
|
2022
Q1 | $3.32M | Sell |
94,752
-12,274
| -11% | -$430K | ﹤0.01% | 1560 |
|
|
2021
Q4 | $3.47M | Buy |
107,026
+55,029
| +106% | +$1.78M | ﹤0.01% | 1561 |
|
|
2021
Q3 | $1.53M | Buy |
+51,997
| New | +$1.53M | ﹤0.01% | 1873 |
|